Orange Book product · Generic (ANDA)
LETROZOLE
LETROZOLE
At a glance
Jun 03, 2011
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 03, 2011
15 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
LETROZOLE
Strength
2.5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 091098
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LETROZOLE
- 1997FEMARABrand (NDA)
NDA 020726 · NOVARTIS PHARMS
- 2019LETROZOLEGeneric (ANDA)
ANDA 211717 · EUGIA PHARMA
- 2018LETROZOLEGeneric (ANDA)
ANDA 205869 · BEIJING YILING
- 2016LETROZOLEGeneric (ANDA)
ANDA 203796 · HIKMA PHARMS
- 2014LETROZOLEGeneric (ANDA)
ANDA 202048 · LANNETT CO INC
- 2013LETROZOLEGeneric (ANDA)
ANDA 202716 · CHARTWELL RX
- 2012LETROZOLEGeneric (ANDA)
ANDA 091303 · APOTEX INC
- 2011LETROZOLEGeneric (ANDA)
ANDA 090292 · ACTAVIS TOTOWA
- 2011LETROZOLEGeneric (ANDA)
ANDA 090934 · ACCORD HLTHCARE
- 2011LETROZOLEGeneric (ANDA)
ANDA 091191 · CARNEGIE
- 2011LETROZOLEGeneric (ANDA)
ANDA 090491 · FRESENIUS KABI USA
- 2011LETROZOLEGeneric (ANDA)
ANDA 090838 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
